Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Don't worry too much about the current price because the long-term growth potential and strong market position mean you're still looking at a very bright future ahead.
With the company now uplifted from PN17 status and showing solid recovery in net profit margins alongside healthy cash flows, the current valuation looks attractive for long-term investors aiming for that 30 sen target.
If UPA's earnings keep bleeding while the share price stays stagnant, the valuation is getting way too expensive and you better off parking your money in those other solid counters we talked about.
BPPLAS cash flow strong enough to sustain 8sen dividend, and with their focus on high-margin stretch film, steady long-term growth is definitely within reach.
Looking at Encorp’s financials today, the low valuation reflects the stagnant property market, but if you believe in their long-term project pipeline, it could be a deep value play for the patient investor.
